299 related articles for article (PubMed ID: 38053295)
1. Research progress on hydrogel-based drug therapy in melanoma immunotherapy.
He W; Zhang Y; Qu Y; Liu M; Li G; Pan L; Xu X; Shi G; Hao Q; Liu F; Gao Y
BMB Rep; 2024 Feb; 57(2):71-78. PubMed ID: 38053295
[TBL] [Abstract][Full Text] [Related]
2. Designing Hydrogels for On-Demand Therapy.
Oliva N; Conde J; Wang K; Artzi N
Acc Chem Res; 2017 Apr; 50(4):669-679. PubMed ID: 28301139
[TBL] [Abstract][Full Text] [Related]
3. Locally Injectable Hydrogels for Tumor Immunotherapy.
Zhang X; Guo X; Wu Y; Gao J
Gels; 2021 Nov; 7(4):. PubMed ID: 34842684
[TBL] [Abstract][Full Text] [Related]
4. Injectable Hydrogels as Unique Platforms for Local Chemotherapeutics-Based Combination Antitumor Therapy.
Yu S; He C; Chen X
Macromol Biosci; 2018 Dec; 18(12):e1800240. PubMed ID: 30303620
[TBL] [Abstract][Full Text] [Related]
5. Injectable Hydrogels as Local Depots at Tumor Sites for Antitumor Immunotherapy and Immune-Based Combination Therapy.
Ma H; He C; Chen X
Macromol Biosci; 2021 Jun; 21(6):e2100039. PubMed ID: 33818918
[TBL] [Abstract][Full Text] [Related]
6. Injectable hydrogels for personalized cancer immunotherapies.
Mohaghegh N; Ahari A; Zehtabi F; Buttles C; Davani S; Hoang H; Tseng K; Zamanian B; Khosravi S; Daniali A; Kouchehbaghi NH; Thomas I; Serati Nouri H; Khorsandi D; Abbasgholizadeh R; Akbari M; Patil R; Kang H; Jucaud V; Khademhosseini A; Hassani Najafabadi A
Acta Biomater; 2023 Dec; 172():67-91. PubMed ID: 37806376
[TBL] [Abstract][Full Text] [Related]
7. Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors.
Zheng H; Li M; Wu L; Liu W; Liu Y; Gao J; Lu Z
Drug Deliv; 2023 Dec; 30(1):2161670. PubMed ID: 36587630
[TBL] [Abstract][Full Text] [Related]
8. A review on liposome-based therapeutic approaches against malignant melanoma.
Mirzavi F; Barati M; Soleimani A; Vakili-Ghartavol R; Jaafari MR; Soukhtanloo M
Int J Pharm; 2021 Apr; 599():120413. PubMed ID: 33667562
[TBL] [Abstract][Full Text] [Related]
9. Short Review on Advances in Hydrogel-Based Drug Delivery Strategies for Cancer Immunotherapy.
Seo HS; Wang CJ; Park W; Park CG
Tissue Eng Regen Med; 2022 Apr; 19(2):263-280. PubMed ID: 34596839
[TBL] [Abstract][Full Text] [Related]
10. Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer.
Mikhail AS; Morhard R; Mauda-Havakuk M; Kassin M; Arrichiello A; Wood BJ
Adv Drug Deliv Rev; 2023 Nov; 202():115083. PubMed ID: 37673217
[TBL] [Abstract][Full Text] [Related]
11. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
[TBL] [Abstract][Full Text] [Related]
12. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.
Chen X; Wang M; Yang X; Wang Y; Yu L; Sun J; Ding J
Theranostics; 2019; 9(21):6080-6098. PubMed ID: 31534538
[TBL] [Abstract][Full Text] [Related]
13. Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
Muñoz NM; Williams M; Dixon K; Dupuis C; McWatters A; Avritscher R; Manrique SZ; McHugh K; Murthy R; Tam A; Naing A; Patel SP; Leach D; Hartgerink JD; Young S; Prakash P; Hwu P; Sheth RA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589526
[TBL] [Abstract][Full Text] [Related]
14. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy.
Wu X; Wu Y; Ye H; Yu S; He C; Chen X
J Control Release; 2017 Jun; 255():81-93. PubMed ID: 28408199
[TBL] [Abstract][Full Text] [Related]
16. NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer.
Won JE; Wi TI; Lee CM; Lee JH; Kang TH; Lee JW; Shin BC; Lee Y; Park YM; Han HD
Acta Biomater; 2021 Dec; 136():508-518. PubMed ID: 34626819
[TBL] [Abstract][Full Text] [Related]
17. An injectable supramolecular hydrogel as a self-drug-delivery system for local chemoimmunotherapy against melanoma.
Bera S; Datta HK; Dastidar P
Biomater Sci; 2023 Aug; 11(16):5618-5633. PubMed ID: 37404092
[TBL] [Abstract][Full Text] [Related]
18. Polymer-based hydrogels with local drug release for cancer immunotherapy.
Xie Z; Shen J; Sun H; Li J; Wang X
Biomed Pharmacother; 2021 May; 137():111333. PubMed ID: 33571834
[TBL] [Abstract][Full Text] [Related]
19. Injectable hydrogels of newly designed brush biopolymers as sustained drug-delivery vehicle for melanoma treatment.
Shukla A; Singh AP; Maiti P
Signal Transduct Target Ther; 2021 Feb; 6(1):63. PubMed ID: 33589586
[TBL] [Abstract][Full Text] [Related]
20. Research progress of microneedles in the treatment of melanoma.
Li X; Zhao Z; Zhang M; Ling G; Zhang P
J Control Release; 2022 Aug; 348():631-647. PubMed ID: 35718209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
